Erratum: Metformin treatment for Gestational Diabetes (British Journal of Diabetes and Vascular Disease (2009) 9 (220-225) DOI: 10.1177/1474651409346767);Metformin treatment for gestational diabetes

British Journal of Diabetes and Vascular Disease

Volumn 9, Issue 5, 2009, Pages 220-225

  Hyer, Steve L ^a   Balani, Jyoti ^a   Johnson, Antoinette ^b   Shehata, Hassan ^b  

^a ST HELIER HOSPITAL   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Gestational diabetes; Macrosomia; Metformin

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN LISPRO; METFORMIN;

BEDTIME DOSAGE; DIET THERAPY; DRUG SAFETY; DYSTOCIA; FEMALE; FETUS GROWTH; FETUS WEIGHT; GASTROINTESTINAL SYMPTOM; GESTATIONAL AGE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN TREATMENT; MACROSOMIA; OUTCOME ASSESSMENT; OVARY POLYCYSTIC DISEASE; PREGNANCY DIABETES MELLITUS; REVIEW; RISK FACTOR; SIDE EFFECT; WEIGHT GAIN;

EID: 74549123303     PISSN: 14746514     EISSN: 17534305     Source Type: Journal    
DOI: 10.1177/1474651409358637     Document Type: Erratum

References (26)

1. Reece EA, Homko CJ. Pregnancy outcomes in gestations complicated by type 2 diabetes. Curr Diab Rep 2005;5:269-271
2. Farrell T, Neale L, Cundy T. Congenital anomalies in the offspring of women with type 1, type 2 and gestational diabetes. Diabet Med 2002;19:322-326
3. Boney CM, Verma A, Tucker R, Vohr BR. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Paediatrics 2005;115:e290-6.
4. Hyer SL, Shehata HA. Gestational diabetes mellitus. Curr Obstet Gynaecol 2005;15:368-374
5. Fraser R, Heller SR. Gestational diabetes: aetiology and management. Obstet Gynaecol Reprod Med 2007;17:345-348
6. Crowther CA, Hiller JE, Moss JR et al. The Australian Carbohydrate Intolerance Study in Pregnant Women (ACHOIS) Trial Group. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med 2005;352:2477-2488
7. de Veciana M, Major CA, Morgan MA et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Engl J Med 1995;333: 1237-1241
8. Weisz B, Shrim A, Homko CJ et al. One hour versus two hours postprandial glucose measurement in gestational diabetes: a prospective study. J Perinatol 2005;25:241-244
9. Mathieson ER, Kinsley B, Amiel SA et al. On behalf of the Insulin Aspart Pregnancy Study Group. Maternal glycaemic control and hypoglycaemia in type 1 diabetic pregnancy. Diabetes Care 2007;30:771-776
10. US Food and Drug Administration website: http://www.accessdata,fda,gov/ drugsatfda-docs/label/2008/020357s031,021202s016lbl.pdf (Accessed 7th September 2009).
11. Duncan C. Highlights from the Fifth International Symposium on Diabetes and Pregnancy. Br J Diabetes Vasc Dis 2009;9:139-140
12. Glueck CJ, Goldenberg N, Wang P et al. Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughout pregnancy. Hum Reprod 2004; 19:510-521
13. Hawthorne G. Metformin use and diabetic pregnancy-has its time come? Diab Med 2006;23:223-227
14. Brown FM, Wyckoff J, Rowan JA et al. Metformin in pregnancy: Its time has not yet come. Diabetes Care 2006;29:485-486
15. Hughes RCE, Rowan JA. Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome? Diabet Med 2006;23:318-326
16. Glueck CJ, Wang P, Goldenberg N, Seive-Smith L. Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin. Hum Reprod 2002;17:2858-2864
17. Jakubowicz DJ, Iuorno MJ, Jakubowicz S. Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:524-529
18. Glueck CJ, Bornovali S, Pranikoff J et al. Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome. Diabet Med 2004;21:829-836
19. Glueck CJ, Goldenberg N, Pranikoff J et al. Height, weight, and motorsocial development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Hum Reprod 2004;19:1323-1330
20. Rowan JA, Hague WM, Gao W et al. For the MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008;358:2003-2015
21. Hughes RCE, Gardiner SJ, Begg EJ, Zhang M. Effect of pregnancy on the pharmacokinetics of metformin. Diabet Med 2006;23:323-326
22. Glueck CJ, Salehi M, Sieve L, Wang P. Growth, motor, and social development in breast and formula-fed infants of metformin-treated women with polycystic ovary syndrome. J Pediatr 2006;148:628-632
23. Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in metformin-treated women with gestational diabetes. Diabetologia 2008;51(Suppl 1):S1-S588, 1147.
24. Balani J, Hyer SL, Rodin DA, Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case control study. Diabet Med 2009;26:798-802.
25. Gardosi J, Francis A. Customised Centile Calculator: GROW-Centile v 5.1. Gestation Network, www.gestation.net. Birmingham: Perinatal Institute, 2006.
26. National Institute for Health and Clinical Excellence Diabetes in pregnancy: full guideline. London: NICE, 2008.